Market Overview:
The global polymer prefilled syringe market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for polymer prefilled syringes from the pharmaceutical and biotechnology industries, rising prevalence of chronic diseases, and technological advancements in the field of polymer prefilled syringes. Based on type, the global polymer prefilled syringe market is segmented into COP (cyclic olefin polymer) and COC (cyclic olefin copolymer). The COP segment is expected to account for a larger share of the global market than the COC segment during the forecast period. This can be attributed to its superior properties such as biocompatibility, chemical resistance, thermal stability, and low-friction surface finish.
Product Definition:
A Polymer Prefilled Syringe is a medical device that is used to inject medication or other fluid substances into the body. The syringe typically consists of a barrel, plunger, and needle. The barrel is filled with the desired substance, and the plunger is inserted into the barrel in order to push the substance through the needle and into the body. Polymer Prefilled Syringes are important because they allow for accurate dosing of medications and other fluids, which can be critical in certain medical situations.
COP (Cyclic Olefin Polymer):
Cyclic Olefin Polymer (COP) is a kind of polymer, which consists of cyclohexane and olefins. COP has the ability to be extruded into very thin films and it possesses excellent mechanical strength, toughness & dimensional stability. It can also be used in combination with other polymers such as PE or PET for manufacturing flexible packaging solutions.
COC (Cyclic Olefin Copolymer):
COC (Cyclic Olefin Copolymer) is a kind of polymer, which has high molecular weight and low crystalline melting point. It is produced by the catalytic addition of olefins in the presence of a catalyst such as aluminum or zirconium. COC has applications in various end-use industries including pharmaceuticals, cosmetics, food additives & processing aids and others.
Application Insights:
The antithrombotics application segment led the global polymer prefilled syringe market in 2017. Polymer prefilled syringes are used for anticoagulation of blood during procedures, such as angioplasty and cardiac catheterization. The growing prevalence of thrombosis due to factors, such as immobility and obesity is expected to drive the demand for these devices over the forecast period.
Polymer-based devices have a number of advantages over metal ones in terms of patient safety and cost-effectiveness; this is expected to propel their usage across various applications during the forecast period. Other applications include vaccines, biologics (recombinant proteins) administration, chemotherapy drug delivery systems among others. Increasing government support towards immunization programs against a wide range of diseases including chickenpox, diphtheria & tetanus toxoids & pertussis vaccine is anticipated to further boost product demand in immunization programs across various regions during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D activities and rising healthcare spending in U.S., which has led to an increased demand for pre-filled syringes across various applications.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure, growing population, and rising awareness regarding advanced medical technologies among end users of polymer pre-filled syringes are vaccines & biologics). In addition, increasing incidence of chronic diseases due to unhealthy lifestyles will drive regional market growth over the next eight years (2018 - 2030). Moreover, government initiatives encouraging domestic manufacturing are likely boost regional product demand over the coming years.
Growth Factors:
- Increasing demand for biologics and monoclonal antibodies: The increasing demand for biologics and monoclonal antibodies is a major growth driver for the polymer prefilled syringe market. Polymer prefilled syringes are widely used to administer these drugs as they offer several benefits such as reduced risk of contamination, improved accuracy, and reduced drug wastage.
- Technological advancements: The development of novel technologies such as self-injection systems is driving the growth of the polymer prefilled syringe market. These systems allow users to inject themselves with medications without help from others, which is contributing to the rising popularity of polymer prefilled syringes among patients and healthcare professionals alike.
- Growing number of product approvals: The growing number of product approvals by regulatory agencies is another key factor that is fueling the growth of the polymer prefilled syringe market worldwide. In addition, increasing investments in research and development by leading players in this market are resulting in new product launches, thereby propelling its growth further.
Scope Of The Report
Report Attributes
Report Details
Report Title
Polymer Prefilled Syringe Market Research Report
By Type
COP (Cyclic Olefin Polymer), COC (Cyclic Olefin Copolymer), Other
By Application
Antithrombotics, Vaccines, Biologics, Other
By Companies
BD, Gerresheimer, Nipro Corporation, Schott, Baxter BioPharma Solution, Rovi CM, Terumo, Vetter, Catalent, Taisei Kako, Roselabs Group, West Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
159
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Polymer Prefilled Syringe Market Report Segments:
The global Polymer Prefilled Syringe market is segmented on the basis of:
Types
COP (Cyclic Olefin Polymer), COC (Cyclic Olefin Copolymer), Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Antithrombotics, Vaccines, Biologics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD
- Gerresheimer
- Nipro Corporation
- Schott
- Baxter BioPharma Solution
- Rovi CM
- Terumo
- Vetter
- Catalent
- Taisei Kako
- Roselabs Group
- West Pharma
Highlights of The Polymer Prefilled Syringe Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- COP (Cyclic Olefin Polymer)
- COC (Cyclic Olefin Copolymer)
- Other
- By Application:
- Antithrombotics
- Vaccines
- Biologics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Polymer Prefilled Syringe Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A polymer prefilled syringe is a prefilled syringe that contains a polymer solution. Polymer solutions are often used in medical procedures because they are non-toxic and have a long shelf life.
Some of the major companies in the polymer prefilled syringe market are BD, Gerresheimer, Nipro Corporation, Schott, Baxter BioPharma Solution, Rovi CM, Terumo, Vetter, Catalent, Taisei Kako, Roselabs Group, West Pharma.
The polymer prefilled syringe market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Polymer Prefilled Syringe Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Polymer Prefilled Syringe Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Polymer Prefilled Syringe Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Polymer Prefilled Syringe Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Polymer Prefilled Syringe Market Size & Forecast, 2020-2028
4.5.1 Polymer Prefilled Syringe Market Size and Y-o-Y Growth
4.5.2 Polymer Prefilled Syringe Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 COP (Cyclic Olefin Polymer)
5.2.2 COC (Cyclic Olefin Copolymer)
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Antithrombotics
6.2.2 Vaccines
6.2.3 Biologics
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Polymer Prefilled Syringe Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Polymer Prefilled Syringe Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 COP (Cyclic Olefin Polymer)
9.6.2 COC (Cyclic Olefin Copolymer)
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Antithrombotics
9.10.2 Vaccines
9.10.3 Biologics
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 COP (Cyclic Olefin Polymer)
10.6.2 COC (Cyclic Olefin Copolymer)
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Antithrombotics
10.10.2 Vaccines
10.10.3 Biologics
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 COP (Cyclic Olefin Polymer)
11.6.2 COC (Cyclic Olefin Copolymer)
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Antithrombotics
11.10.2 Vaccines
11.10.3 Biologics
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 COP (Cyclic Olefin Polymer)
12.6.2 COC (Cyclic Olefin Copolymer)
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Antithrombotics
12.10.2 Vaccines
12.10.3 Biologics
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 COP (Cyclic Olefin Polymer)
13.6.2 COC (Cyclic Olefin Copolymer)
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Antithrombotics
13.10.2 Vaccines
13.10.3 Biologics
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Polymer Prefilled Syringe Market: Competitive Dashboard
14.2 Global Polymer Prefilled Syringe Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BD
14.3.2 Gerresheimer
14.3.3 Nipro Corporation
14.3.4 Schott
14.3.5 Baxter BioPharma Solution
14.3.6 Rovi CM
14.3.7 Terumo
14.3.8 Vetter
14.3.9 Catalent
14.3.10 Taisei Kako
14.3.11 Roselabs Group
14.3.12 West Pharma
